Erk1/2 activates both Nrf2 and PGC-1α via phosphorylation of the serine/threonine kinase LKB1 (liver kinase B1), a known tumor suppressor, which in turn phosphorylates AMPK [134]. The gene discussed is STK11; the disease is neoplasm.